Investigating how genetic mutations in brain cells affect Alzheimer's disease

Role of clonal somatic mutations in microglia activation and Alzheimer’s disease

['FUNDING_OTHER'] · BOSTON CHILDREN'S HOSPITAL · NIH-10901003

This study is looking at how certain genetic changes in the brain's immune cells, called microglia, might affect Alzheimer's disease as people get older, and it hopes to find new ways to help treat the condition.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorBOSTON CHILDREN'S HOSPITAL (nih funded)
Locations1 site (BOSTON, UNITED STATES)
Trial IDNIH-10901003 on ClinicalTrials.gov

What this research studies

This research explores the role of clonal somatic mutations in microglia, the brain's immune cells, and their connection to Alzheimer's disease (AD). By examining how these mutations accumulate with age, the study aims to understand their impact on neuroinflammation and neuronal loss in AD. Patients with Alzheimer's may have specific genetic changes in their microglia that contribute to disease progression, and this research will utilize advanced sequencing technologies to analyze these mutations. The findings could lead to new insights into the mechanisms of AD and potential therapeutic targets.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk due to age and genetic factors.

Not a fit: Patients with non-neurodegenerative conditions or those without a diagnosis of Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's disease by targeting the underlying mechanisms of neuroinflammation.

How similar studies have performed: Previous research has shown promising results in understanding the role of genetic mutations in neurodegenerative diseases, indicating that this approach may yield valuable insights.

Where this research is happening

BOSTON, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.